Pharmapod Limited
Company Summary
Pharmapod Limited was set up on Tuesday the 14th of December 2010. Their current partial address is Dublin 18, and the company status is Liquidation. The company's current directors have been the director of 29 other Irish companies between them; 6 of which are now closed. Pharmapod Limited has 24 shareholders. This Irish company shares its Eircode with at least 637 other companies.
Company Vitals
- Company Name:Pharmapod Limited
- Time in Business:13 Years
- Company Number:492722
- Current Status:Liquidation
- Website:www.pharmapodhq.com
- Phone:+353 (0)1 6852242
- May Trade As:Pharmapod Ltd
- Size:Small Company
- Principal Activity:Software Consultancy and Supply
- Partial Address:Dublin 18
- RiskWatchMEETING OF CREDITORS
Took place on 23/06/2022
Documents
| Document | Pages | Effective | Received |
|---|---|---|---|
| Form E3: Liquidator`s Accounts of Acts & Dealings | 3 | 22/06/2024 | 11/07/2024 |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 5 | 22/06/2024 | 03/07/2024 |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 5 | 22/12/2023 | 12/01/2024 |
| Form E3: Liquidator`s Accounts of Acts & Dealings | 3 | 22/06/2023 | 03/08/2023 |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 5 | 22/06/2023 | 19/07/2023 |
| Form E11: Notice of cessation by receiver | 2 | 21/03/2023 | 26/04/2023 |
| Form E9: Receiver`s Abstract | 4 | 12/10/2022 | 26/04/2023 |
| Form E9: Receiver`s Abstract | 4 | 21/03/2023 | 26/04/2023 |
| Form E2: Notice of Appointment of Liquidator(s) | 2 | 23/06/2022 | 27/06/2022 |
| Form E9: Receiver`s Abstract | 4 | 12/04/2022 | 31/05/2022 |
| Form E8: Notice of Appointment of Receiver | 3 | 13/10/2021 | 19/10/2021 |
| Form B1B73 - Annual Return and Change of ARD | 11 | 14/06/2021 | 09/08/2021 |
| C1 MORTGAGE/CHARGE CREATED BY IRISH COMPANY | 9 | 28/03/2018 | 29/03/2018 |
| A1 APPLICATION TO REGISTER AS A NEW COMPANY, | 4 | 14/12/2010 | 10/12/2010 |
This company has 78 other documents.